Evidence map›Paper›PMID 29305743›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2018

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

J Cassinello, J Á Arranz, J M Piulats, A Sánchez, B Pérez-Valderrama, B Mellado, M Á Climent, D Olmos, J Carles, M Lázaro

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  2. 2017 SEOM guidelines: a multidisciplinary approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

J CassinelloMedical Oncology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain. jcassinelloespinosa@gmail.com.ORCID http://orcid.org/0000-0001-9101-4544
J Á ArranzMedical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
J M PiulatsMedical Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
A SánchezMedical Oncology Department, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain.
B Pérez-ValderramaMedical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
B MelladoMedical Oncology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain.
M Á ClimentMedical Oncology Department, Fundacion Instituto Valenciano de Oncología, Valencia, Spain.
D OlmosCNIO-IBIMA Genito-Urinary Cancer Unit, Medical Oncology Department, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Malaga, Spain.
J CarlesVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
M LázaroMedical Oncology Department, Hospital Universitario de Vigo, Vigo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original article shows two mistakes, which are listed here.

Identifiers

PMID29305743
PMCPMC6828334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.